The Business Of CNS with Acumen's Jim Doherty, Ph.D.
Business Of Biotech
Navigating Alzheimer's Therapeutics
This chapter explores the intricate landscape of developing treatments for Alzheimer's disease, reflecting on historical hurdles and recent innovations. It emphasizes the importance of understanding both scientific and business perspectives in the biotech industry while addressing controversies surrounding new drug approvals. The conversation also highlights the critical role of biomarkers and teamwork in achieving meaningful progress toward effective therapies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
